Sysmex (OTCMKTS:SSMXY) Shares Gap Down – Here’s What Happened

Posted by Patrick Bannon on Sep 11th, 2026

Sysmex Corporation ADR (OTCMKTS:SSMXY – Get Free Report) gapped down prior to trading on Wednesday . The stock had previously closed at $12.43, but opened at $11.9150. Sysmex shares last traded at $11.85, with a volume of 103,093 shares traded.

Analyst Upgrades and Downgrades

Separately, Zacks Research upgraded Sysmex from a “strong sell” rating to a “hold” rating in a research report on Tuesday, August 18th. One equities research analyst has rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold”.

Read Our Latest Stock Analysis on Sysmex

Sysmex Stock Down 3.2%

The business’s 50 day simple moving average is $10.91 and its 200 day simple moving average is $9.54. The company has a market capitalization of $7.21 billion, a PE ratio of 27.26 and a beta of 1.09. The company has a quick ratio of 2.46, a current ratio of 3.40 and a debt-to-equity ratio of 0.23.

Sysmex (OTCMKTS:SSMXY – Get Free Report) last issued its quarterly earnings results on Friday, August 7th. The company reported $0.09 EPS for the quarter, beating the consensus estimate of $0.07 by $0.02. Sysmex had a net margin of 7.62% and a return on equity of 8.01%. The business had revenue of $825.85 million during the quarter, compared to the consensus estimate of $741.67 million. Sysmex has set its FY 2026 guidance at 0.382-0.382 EPS. As a group, analysts forecast that Sysmex Corporation ADR will post 0.38 EPS for the current year.

Sysmex Company Profile

(Get Free Report)

Sysmex Corporation is a Japan-based healthcare technology company that develops, manufactures and sells diagnostic instruments, reagents and related information systems. Its products are primarily used in clinical laboratories, hospitals and other healthcare settings to support the analysis of blood, urine and other biological samples.

The company is best known for its hematology testing systems, including automated analyzers used to assess blood cell counts and related parameters. Its portfolio also includes products for hemostasis and coagulation testing, urinalysis, clinical chemistry, immunochemistry and flow cytometry, as well as laboratory information systems, maintenance and other support services.

Sysmex was established in 1968 and is headquartered in Kobe, Japan.